vonoprazan
Generic: vonoprazan·Brand: VOQUEZNA, Voquezna
vonoprazan: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | Phase 3 |
Clinical Trials (1)
A Phase 1, Open-label Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
Frequently asked questions
Who is developing vonoprazan?
vonoprazan is being developed by Phathom Pharmaceuticals, Inc..
How many clinical trials involve vonoprazan?
BioSniper tracks 1 clinical trial involving vonoprazan.
Get deeper analysis on vonoprazan
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis